Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study)

Stephen L. Curry, John B. Schlaerth, Ernest I. Kohorn, John B. Boyce, Hazel Gore, Leo B. Twiggs, John A. Blessing

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

A prospective randomized study was undertaken to determine whether the administration of oral contraceptives after the evacuation of a hydatidiform mole affects the human chorionic gonadotropin serum level in a way that leads to an increased frequency in the diagnosis of postmolar trophoblastic disease. Between 1981 and 1988, 266 patients were randomly assigned to either oral contraceptives or barrier contraception after evacuation of a hydatidiform mole. Patients were followed up until serum levels of human chorionic gonadotropin were normal or until specific criteria for the diagnosis of postmolar trophoblastic disease were met. Twenty-three percent of patients receiving oral contraceptives had postmolar trophoblastic disease, whereas those using a barrier method had a rate of 33%. The median time to spontaneous regression in the oral contraceptives group was 9 weeks, whereas the median time to regression in the barrier group was 10 weeks. Twice as many patients in the barrier group became pregnant in the immediate follow-up period. We conclude that oral contraceptives are the preferred method of contraception after evacuation of a hydatidiform mole.

Original languageEnglish
Pages (from-to)805-811
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume160
Issue number4
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Hydatidiform Mole
Oral Contraceptives
Contraception
Chorionic Gonadotropin
Barrier Contraception
Serum
Prospective Studies

Keywords

  • contraception
  • gestational trophoblastic disease
  • Hydatidiform mole

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Curry, S. L., Schlaerth, J. B., Kohorn, E. I., Boyce, J. B., Gore, H., Twiggs, L. B., & Blessing, J. A. (1989). Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study). American Journal of Obstetrics and Gynecology, 160(4), 805-811. https://doi.org/10.1016/0002-9378(89)90295-0

Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study). / Curry, Stephen L.; Schlaerth, John B.; Kohorn, Ernest I.; Boyce, John B.; Gore, Hazel; Twiggs, Leo B.; Blessing, John A.

In: American Journal of Obstetrics and Gynecology, Vol. 160, No. 4, 01.01.1989, p. 805-811.

Research output: Contribution to journalArticle

Curry, Stephen L. ; Schlaerth, John B. ; Kohorn, Ernest I. ; Boyce, John B. ; Gore, Hazel ; Twiggs, Leo B. ; Blessing, John A. / Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study). In: American Journal of Obstetrics and Gynecology. 1989 ; Vol. 160, No. 4. pp. 805-811.
@article{bfa83621fc5545b3bc517557261922ef,
title = "Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study)",
abstract = "A prospective randomized study was undertaken to determine whether the administration of oral contraceptives after the evacuation of a hydatidiform mole affects the human chorionic gonadotropin serum level in a way that leads to an increased frequency in the diagnosis of postmolar trophoblastic disease. Between 1981 and 1988, 266 patients were randomly assigned to either oral contraceptives or barrier contraception after evacuation of a hydatidiform mole. Patients were followed up until serum levels of human chorionic gonadotropin were normal or until specific criteria for the diagnosis of postmolar trophoblastic disease were met. Twenty-three percent of patients receiving oral contraceptives had postmolar trophoblastic disease, whereas those using a barrier method had a rate of 33{\%}. The median time to spontaneous regression in the oral contraceptives group was 9 weeks, whereas the median time to regression in the barrier group was 10 weeks. Twice as many patients in the barrier group became pregnant in the immediate follow-up period. We conclude that oral contraceptives are the preferred method of contraception after evacuation of a hydatidiform mole.",
keywords = "contraception, gestational trophoblastic disease, Hydatidiform mole",
author = "Curry, {Stephen L.} and Schlaerth, {John B.} and Kohorn, {Ernest I.} and Boyce, {John B.} and Hazel Gore and Twiggs, {Leo B.} and Blessing, {John A.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0002-9378(89)90295-0",
language = "English",
volume = "160",
pages = "805--811",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study)

AU - Curry, Stephen L.

AU - Schlaerth, John B.

AU - Kohorn, Ernest I.

AU - Boyce, John B.

AU - Gore, Hazel

AU - Twiggs, Leo B.

AU - Blessing, John A.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - A prospective randomized study was undertaken to determine whether the administration of oral contraceptives after the evacuation of a hydatidiform mole affects the human chorionic gonadotropin serum level in a way that leads to an increased frequency in the diagnosis of postmolar trophoblastic disease. Between 1981 and 1988, 266 patients were randomly assigned to either oral contraceptives or barrier contraception after evacuation of a hydatidiform mole. Patients were followed up until serum levels of human chorionic gonadotropin were normal or until specific criteria for the diagnosis of postmolar trophoblastic disease were met. Twenty-three percent of patients receiving oral contraceptives had postmolar trophoblastic disease, whereas those using a barrier method had a rate of 33%. The median time to spontaneous regression in the oral contraceptives group was 9 weeks, whereas the median time to regression in the barrier group was 10 weeks. Twice as many patients in the barrier group became pregnant in the immediate follow-up period. We conclude that oral contraceptives are the preferred method of contraception after evacuation of a hydatidiform mole.

AB - A prospective randomized study was undertaken to determine whether the administration of oral contraceptives after the evacuation of a hydatidiform mole affects the human chorionic gonadotropin serum level in a way that leads to an increased frequency in the diagnosis of postmolar trophoblastic disease. Between 1981 and 1988, 266 patients were randomly assigned to either oral contraceptives or barrier contraception after evacuation of a hydatidiform mole. Patients were followed up until serum levels of human chorionic gonadotropin were normal or until specific criteria for the diagnosis of postmolar trophoblastic disease were met. Twenty-three percent of patients receiving oral contraceptives had postmolar trophoblastic disease, whereas those using a barrier method had a rate of 33%. The median time to spontaneous regression in the oral contraceptives group was 9 weeks, whereas the median time to regression in the barrier group was 10 weeks. Twice as many patients in the barrier group became pregnant in the immediate follow-up period. We conclude that oral contraceptives are the preferred method of contraception after evacuation of a hydatidiform mole.

KW - contraception

KW - gestational trophoblastic disease

KW - Hydatidiform mole

UR - http://www.scopus.com/inward/record.url?scp=0024566504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024566504&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(89)90295-0

DO - 10.1016/0002-9378(89)90295-0

M3 - Article

C2 - 2540654

AN - SCOPUS:0024566504

VL - 160

SP - 805

EP - 811

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -